Technical Analysis for OSIR - Osiris Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 15.92 4.60% 0.70
OSIR closed up 4.6 percent on Friday, February 15, 2019, on 1.6 times normal volume. The bulls were able to push the stock to a new 52-week high.

Earnings due: Feb 20

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical OSIR trend table...

Date Alert Name Type % Chg
Feb 15 New 52 Week Closing High Bullish 0.00%
Feb 15 Pocket Pivot Bullish Swing Setup 0.00%
Feb 15 New 52 Week High Strength 0.00%
Feb 15 BB Squeeze Ended Range Expansion 0.00%
Feb 15 Upper Bollinger Band Touch Strength 0.00%
Feb 14 Bollinger Band Squeeze Range Contraction 4.60%
Feb 14 Narrow Range Bar Range Contraction 4.60%
Feb 14 NR7 Range Contraction 4.60%
Feb 14 NR7-2 Range Contraction 4.60%
Feb 14 Earnings Movers Other 4.60%

Older signals for OSIR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Osiris Therapeutics, Inc. is a cellular and regenerative medicine company. The Company is focused on researching, developing and marketing products in the wound, orthopedic, and sports medicine markets. The Company operates through Biosurgery business segment, which focuses on products for wound care, orthopedics, and sports medicine to harness the ability of cells and novel constructs to promote the body's natural healing. The Company's products include Grafix, Stravix, TruSkin, Cartiform and BIO4. The Company produces and distributes Grafix for acute and chronic wounds; Stravix for tendon repair; TruSkin for wound closure; Cartiform, a viable cartilage mesh for cartilage repair, and BIO4 for bone growth. The Company's BioSmart cryopreservation process retains the native characteristics and inherent functionality of tissue. Its BioSmart process includes preservation of the three dimensional (3D) matrix, endogenous growth factors, and tissue-resident cells.
Biology Emerging Technologies Regenerative Medicine Tissue Engineering Sports Medicine Cartilage Regenerative Biomedicine Cryopreservation
Is OSIR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.0
52 Week Low 7.3
Average Volume 112,878
200-Day Moving Average 0.0
50-Day Moving Average 13.8372
20-Day Moving Average 14.964
10-Day Moving Average 15.409
Average True Range 0.6697
ADX 21.93
+DI 30.1995
-DI 17.4248
Chandelier Exit (Long, 3 ATRs ) 13.9909
Chandelier Exit (Short, 3 ATRs ) 15.5691
Upper Bollinger Band 15.9723
Lower Bollinger Band 13.9557
Percent B (%b) 0.97
BandWidth 13.476343
MACD Line 0.5254
MACD Signal Line 0.5506
MACD Histogram -0.0252
Fundamentals Value
Market Cap 548.48 Million
Num Shares 34.5 Million
EPS 0.04
Price-to-Earnings (P/E) Ratio 398.00
Price-to-Sales 1.89
Price-to-Book 2.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.30
Resistance 3 (R3) 17.17 16.59 17.07
Resistance 2 (R2) 16.59 16.24 16.65 16.99
Resistance 1 (R1) 16.25 16.02 16.42 16.38 16.92
Pivot Point 15.67 15.67 15.75 15.73 15.67
Support 1 (S1) 15.33 15.32 15.50 15.46 14.92
Support 2 (S2) 14.75 15.10 14.81 14.85
Support 3 (S3) 14.41 14.75 14.77
Support 4 (S4) 14.54